Search results

Thanks for the link. I had a look and it seems product as efficacy not only on cepacia but also pseudo and mrsa I'll try to know a little bit more by contacting them

Thanks for the link. I had a look and it seems product as efficacy not only on cepacia but also pseudo and mrsa I'll try to know a little bit more by contacting them

Thanks for the link. I had a look and it seems product as efficacy not only on cepacia but also pseudo and mrsa I'll try to know a little bit more by contacting them

Thanks for the link. I had a look and it seems product as efficacy not only on cepacia but also pseudo and mrsa I'll try to know a little bit more by contacting them

Thanks for the link. I had a look and it seems product as efficacy not only on cepacia but also pseudo and mrsa <br />I'll try to know a little bit more by contacting them <br />

Yes, Your are right In Europe, 27 years old is the average given by some surveys. We think, it is a little bit higher and should be between 30 to 35

Yes, Your are right In Europe, 27 years old is the average given by some surveys. We think, it is a little bit higher and should be between 30 to 35

Yes, Your are right In Europe, 27 years old is the average given by some surveys. We think, it is a little bit higher and should be between 30 to 35

Yes, Your are right In Europe, 27 years old is the average given by some surveys. We think, it is a little bit higher and should be between 30 to 35

Yes, Your are right <br />In Europe, 27 years old is the average given by some surveys. <br />We think, it is a little bit higher and should be between 30 to 35

In Europe, as seen on EMEA website (EMEA is the European medical agency, especially in charge of Orphan designation) Prevalence is 1 CF/10,000 inhabitants (As 500 Millions, you can do the calculation) Higher prevalency in Ireland (nearly 3 this mean more 1000 for this tiny country), lower in...

In Europe, as seen on EMEA website (EMEA is the European medical agency, especially in charge of Orphan designation) Prevalence is 1 CF/10,000 inhabitants (As 500 Millions, you can do the calculation) Higher prevalency in Ireland (nearly 3 this mean more 1000 for this tiny country), lower in...

In Europe, as seen on EMEA website (EMEA is the European medical agency, especially in charge of Orphan designation) Prevalence is 1 CF/10,000 inhabitants (As 500 Millions, you can do the calculation) Higher prevalency in Ireland (nearly 3 this mean more 1000 for this tiny country), lower in...

In Europe, as seen on EMEA website (EMEA is the European medical agency, especially in charge of Orphan designation) Prevalence is 1 CF/10,000 inhabitants (As 500 Millions, you can do the calculation) Higher prevalency in Ireland (nearly 3 this mean more 1000 for this tiny country), lower in...

In Europe, as seen on EMEA website (EMEA is the European medical agency, especially in charge of Orphan designation) <br />Prevalence is 1 CF/10,000 inhabitants (As 500 Millions, you can do the calculation) <br /> <br />Higher prevalency in Ireland (nearly 3 this mean more 1000 for this tiny...

I heard from a colleague attending a conference, a new product called Meveol is efficient vs cepacia. Someone has more info ?

I heard from a colleague attending a conference, a new product called Meveol is efficient vs cepacia. Someone has more info ?

I heard from a colleague attending a conference, a new product called Meveol is efficient vs cepacia. Someone has more info ?

I heard from a colleague attending a conference, a new product called Meveol is efficient vs cepacia. Someone has more info ?

I heard from a colleague attending a conference, a new product called Meveol is efficient vs cepacia. <br />Someone has more info ?